Skip to main content


Fig. 3 | Cancer Cell International

Fig. 3

From: SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer

Fig. 3

SLC25A22 plays a vital role in GBC metastasis and proliferation in vivo. a SLC25A22 inhibited cell growth in vivo as observed with a subcutaneous xenograft model. b The tumor volumes were measured once a week from the 10th day and the results are shown on the line chart (*p < 0.05, **p < 0.01). Tumor were weighed when the mice were sacrificed and the data was displayed on the scatter plot chart (*p < 0.05). c, d IHC staining of tumor xenografts for Ki67 and p-ERK. The percentage of Ki67 and p-ERK positive cells are shown in the graph bar (*p < 0.05, **p < 0.01)

Back to article page